Diadema Partners »

Alumis shares owned by Diadema Partners

Quarter-by-quarter ownership of Alumis (ALMS) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Alumis

Tip: Access up to 7 years of quarterly data

All positions including Alumis held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alumis by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.9M 131k 22.03

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Alumis

BlackRock
Deep Track Capital
Samsara BioCapital
Foresite Capital Management V
venBio Partners
Foresite Capital Management VI
Vanguard Capital Management
Cormorant Asset Management
Nextech Invest
Saturn V Capital Management
UBS Group
Octagon Capital Advisors
MPM Oncology Impact Management
Henderson Group
Baker Bros. Advisors

View all funds holding Alumis